1. Roth LM, Anderson MC. Sertoli Leydig cell tumors: a clinicopathologic study of 34 cases. Cancer. 1981. 48:187–197.
2. Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2005. 29:143–156.
3. Pride GL, Pollock WJ, Norgard MJ. Metastatic Sertoli-Leydig cell tumor of the ovary during pregnancy treated by BV-CAP chemotherapy. Am J Obstet Gynecol. 1982. 143:231–233.
4. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985. 9:543–569.
5. Sachdeva P, Arora R, Dubey C, Sukhija A, Daga M, Singh DK. Sertoli-Leydig cell tumor: a rare ovarian neoplasm: case report and review of literature. Gynecol Endocrinol. 2008. 24:230–234.
6. Metzinger DS, Webb MJ. Surgical management of Sertoli-Leydig cell tumors of the ovary. CME J Gynecol Oncol. 2002. 7:140–142.
7. Zheng W, Senturk BZ, Parkash V. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors. Adv Anat Pathol. 2003. 10:27–38.
8. Toppari J, Kaipia A, Kaleva M, Laato M, de Kretser DM, Krummen LA, et al. Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels. APMIS. 1998. 106:101–112.
9. Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawata H. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli-Leydig tumour). Clin Endocrinol (Oxf). 1990. 33:613–618.